iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 66 full-time employees. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a two-dimensional or three-dimensional mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting and algorithmically examining.

Industry: Surgical & Medical Instruments & Apparatus Peers: Augmedix, Inc. Better Therapeutics, Inc. Biotricity Inc CareCloud Inc MediXall Group, Inc. STREAMLINE HEALTH SOLUTIONS INC. MobileSmith, Inc. NantHealth, Inc.